Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morris

Showing results (341-350 of 435) with videos related to

Pageof 44
Sort By:
Journal of Surgical Oncology|January 31, 2009
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritoneiTerence C Chua, Tristan D Yan, Zhu L Yap, et al.
International Journal of Clinical Oncology|November 10, 2010
Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysisTerence C Chua, Akshat Saxena, Francis Chu, et al.
Human Molecular Genetics|December 15, 2010
Dense mapping of IL18 shows no association in SLESandra G Guerra, David L Morris, Vesela Gateva, et al.
Anticancer Research|November 4, 2021
Postoperative Pancreatic Fistula After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Update on Incidence, Risk Factors, Management, and Clinical Sequelae in 1,141 PatientsAmer Matar, Thomas Meares, Oliver M Fisher, et al.
Journal of Cell Science|February 28, 2013
Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motilityHsiao-Wen Su, Nathan J Lanning, David L Morris, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapyRaphael Shamavonian, Rohan McLachlan, Oliver M Fisher, et al.
Cancer|June 22, 2010
Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinomaTerence C Chua, Francis Chu, S Patrick Butler, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2009
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancerMohammad H Pourgholami, Michael Szwajcer, Melvin Chin, et al.
World Journal of Surgery|September 26, 2002
Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat modelJoachim K Seifert, Malcolm P France, Jing Zhao, et al.
Anticancer Research|December 8, 2019
Volume-Time Index Is Not an Indicator of Outcome for Patients Undergoing CRS/HIPEC for Treatment of High-Grade Appendiceal CarcinomatosisDaniel M Dotta, Joshua D Lansom, Oliver M Fisher, et al.
Pageof 44

Showing results (341-350 of 435) with videos related to

Sort By:
Pageof 44
Journal of Surgical Oncology|January 31, 2009
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritoneiTerence C Chua, Tristan D Yan, Zhu L Yap, et al.
International Journal of Clinical Oncology|November 10, 2010
Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysisTerence C Chua, Akshat Saxena, Francis Chu, et al.
Human Molecular Genetics|December 15, 2010
Dense mapping of IL18 shows no association in SLESandra G Guerra, David L Morris, Vesela Gateva, et al.
Anticancer Research|November 4, 2021
Postoperative Pancreatic Fistula After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Update on Incidence, Risk Factors, Management, and Clinical Sequelae in 1,141 PatientsAmer Matar, Thomas Meares, Oliver M Fisher, et al.
Journal of Cell Science|February 28, 2013
Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motilityHsiao-Wen Su, Nathan J Lanning, David L Morris, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapyRaphael Shamavonian, Rohan McLachlan, Oliver M Fisher, et al.
Cancer|June 22, 2010
Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinomaTerence C Chua, Francis Chu, S Patrick Butler, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2009
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancerMohammad H Pourgholami, Michael Szwajcer, Melvin Chin, et al.
World Journal of Surgery|September 26, 2002
Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat modelJoachim K Seifert, Malcolm P France, Jing Zhao, et al.
Anticancer Research|December 8, 2019
Volume-Time Index Is Not an Indicator of Outcome for Patients Undergoing CRS/HIPEC for Treatment of High-Grade Appendiceal CarcinomatosisDaniel M Dotta, Joshua D Lansom, Oliver M Fisher, et al.
Pageof 44